Expression of Gonadotropin-Releasing Hormone Receptor in Human Epithelial Ovarian Carcinoma
Authors:
- Tsukasa OhnoTOTsukasa Ohno
- Teruhiko TamayaTTTeruhiko Tamaya
- 1 November 1994
- journal article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 31 (6) , 550-555
Abstract
We have previously demonstrated the presence of gonadotropin-releasing hormone (Gn-RH) messenger ribonucleic acid (mRNA) in epithelial ovarian carcinoma. In this study, the expression of Gn-RH receptor (Gn-RHR) was investigated in human ovarian carcinoma and human ovarian carcinoma cell line. Gn-RHR was determined by [ 3 H] Gn-RH binding assay. Gn-RHR mRNA was determined by reverse transcription-polymerase chain reaction using oligonucleotide primers synthesized based on published human Gn-RHR sequence. Specific Gn-RH binding sites were shown to be present in plasma membrane isolated from five ovarian mucinous cystadenocarcinoma samples and one serous cystadenocarcinoma ( Kd = 15·3 ± 8·08 nmol/L). Gn-RHR mRNA was detected in four mucinous cystadenocarcinoma specimens, one serous cystadenocarcinoma, and SK-OV-3 cells, but not in white blood cells. These results suggest that Gn-RH may play an autocrine regulatory role in the growth of ovarian carcinoma.Keywords
This publication has 35 references indexed in Scilit:
- Gonadotropin-releasing hormone stimulates phospholipase C but not protein phosphorylation/ déphosphorylation in plasma membrane from human epithelial ovarian cancerInternational Journal of Gynecological Cancer, 1993
- Tight Coupling of Gonadotropin-Releasing Hormone Receptor to Stimulated Phosphoinositide Turnover and Antigonadotropic Action in Granulosa CellsGynecologic and Obstetric Investigation, 1992
- Photoaffinity labelling of gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomataBiochemical and Biophysical Research Communications, 1989
- Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomataEuropean Journal of Cancer and Clinical Oncology, 1989
- Receptors for luteinizing hormone‐releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasiaThe Prostate, 1989
- Treatment of experimental ovarian carcinoma with monthly injection of the agonist D-Trp-6-LH-RH: A preliminary reportCancer Letters, 1988
- Prolactin and luteinizing hormone‐releasing hormone receptors in human benign prostatic hyperplasia and prostate cancerThe Prostate, 1988
- Inhibitory effect of GnRH superagonist on the growth of human ovarian carcinoma NIH: OVCAR 3 in the nude mouseGynecologic Oncology, 1986
- Specific binding of luteinizing hormone releasing hormone to human luteal tissueBiochemical and Biophysical Research Communications, 1983
- Human placental receptors for luteinizing hormone releasing hormoneBiochemical and Biophysical Research Communications, 1981